FUT8 Antibody (Center) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9BYC5 |
---|---|
Clone Names | 81020104 |
Gene ID | 2530 |
---|---|
Other Names | Alpha-(1, 6)-fucosyltransferase, Alpha1-6FucT, Fucosyltransferase 8, GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1, 6-fucosyltransferase, GDP-fucose--glycoprotein fucosyltransferase, Glycoprotein 6-alpha-L-fucosyltransferase, FUT8 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | FUT8 |
---|---|
Function | Catalyzes the addition of fucose in alpha 1-6 linkage to the first GlcNAc residue, next to the peptide chains in N-glycans. |
Cellular Location | Golgi apparatus, Golgi stack membrane; Single-pass type II membrane protein Note=Membrane-bound form in trans cisternae of Golgi. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This enzyme belongs to the family of fucosyltransferases.The product of this gene catalyzes the transfer of fucose fromGDP-fucose to N-linked type complex glycopeptides. This enzyme isdistinct from other fucosyltransferases which catalyze alpha1-2,alpha1-3, and alpha1-4 fucose addition. The expression of this genemay contribute to the malignancy of cancer cells and to theirinvasive and metastatic capabilities. Alternatively splicedvariants encoding different isoforms have been identified.
References
Rose, J. Phd, et al. Mol. Med. (2010) In press :Wang, X., et al. J. Biochem. 145(5):643-651(2009)Kudo, T., et al. Mol. Cancer 6, 32 (2007) :Ihara, H., et al. Glycobiology 16(4):333-342(2006)Ito, Y., et al. Cancer Lett. 200(2):167-172(2003)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.